KOSELUGO vs SUTENT

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Possible drug interaction. KOSELUGO and SUTENT are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	KOSELUGO	SUTENT
Rating	70/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	SELUMETINIB SULFATE	SUNITINIB MALATE
Manufacturer	Astrazeneca	Cppi Cv
Dosage forms	Capsule, Powder	Capsule
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	Boxed warning
Treats	Neurofibromatosis 1	Renal Cell Carcinoma, Pancreatic Neoplasms, Neuroendocrine Tumors

koselugo sutent

Rating

70/100

New

Pharmacy pays

—

Type

Active ingredient

SELUMETINIB SULFATE

SUNITINIB MALATE

Manufacturer

Astrazeneca

Cppi Cv

Dosage forms

Capsule, Powder

Capsule

Drug class

Kinase Inhibitor

Boxed warning

None

Boxed warning

Treats

Neurofibromatosis 1

Renal Cell Carcinoma, Pancreatic Neoplasms, Neuroendocrine Tumors

Frequently asked questions

What is the difference between Koselugo and Sutent?

Koselugo contains Selumetinib Sulfate, while Sutent contains Sunitinib Malate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.